The score is held back primarily by weak financial performance—ongoing losses, negative operating cash flow, and relatively high leverage—despite strong revenue growth and improving free cash flow. Technicals are currently a positive, with the stock well above major moving averages and positive MACD, but the very high RSI indicates overbought risk. Valuation remains constrained by negative earnings and no dividend yield data.
Positive Factors
Revenue Growth
Sustained TTM revenue growth indicates successful market penetration and product demand across clients and industries. Over 2-6 months this supports scaling potential, bolsters recurring contract negotiations, and provides a foundation to invest in product development and sales expansion while customer traction builds.
Free Cash Flow Improvement
A large improvement in free cash flow signals the business is improving cash conversion from operations and investments. This durable improvement reduces immediate funding pressure, enhances the ability to fund R&D or pay down debt, and strengthens liquidity over the medium term.
Diversified Revenue Model
Multiple revenue streams — project fees, subscriptions, maintenance, partnership co-development and licensing — lower customer concentration and seasonality risk. Structurally, recurring subscription and maintenance income can stabilize cash flow and support higher lifetime value customers.
Negative Factors
Persistent Negative Profitability
Ongoing negative margins indicate core operations are not yet profitable, limiting internal reinvestment and forcing reliance on external capital. Over several months this constrains margin expansion potential, increases sensitivity to revenue slowdowns, and delays sustainable earnings generation.
Negative Operating Cash Flow
Negative operating cash flow despite improved free cash flow suggests core operations still consume cash. This structural cash burn necessitates external financing or asset sales to fund growth, increasing execution risk and potentially diluting shareholders or raising leverage over the medium term.
Elevated Leverage and Negative ROE
Relatively high debt-to-equity and negative return on equity increase solvency and interest-cost risks. Structurally, leverage limits financial flexibility for acquisitions or R&D, raises fixed costs, and magnifies downside in cyclical revenue periods, prolonging recovery to positive shareholder returns.
Razor Labs (RZR) vs. iShares MSCI Israel ETF (EIS)
Market Cap
₪227.22M
Dividend YieldN/A
Average Volume (3M)28.25K
Price to Earnings (P/E)―
Beta (1Y)0.36
Revenue Growth238.35%
EPS Growth-0.43%
CountryIL
Employees41
SectorTechnology
Sector Strength88
IndustrySoftware - Infrastructure
Share Statistics
EPS (TTM)-0.39
Shares Outstanding39,413,180
10 Day Avg. Volume34,929
30 Day Avg. Volume28,252
Financial Highlights & Ratios
PEG Ratio0.82
Price to Book (P/B)19.42
Price to Sales (P/S)12.57
P/FCF Ratio-381.66
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Razor Labs Business Overview & Revenue Model
Company DescriptionRazor Labs operates in the artificial intelligence (AI) industry in Israel. It offers DataMind, an industrial optimization platform to take manufacturing process into a virtual world; and AI pipeline, a video analytics platform to chain together various AI applications into one solution that fit corporate objectives. The company is based in Tel Aviv, Israel.
How the Company Makes MoneyRazor Labs generates revenue through a diversified model that includes project-based consulting fees, subscription services for its proprietary software platforms, and ongoing maintenance contracts with clients. The company also engages in strategic partnerships with industry leaders to co-develop AI solutions, which provides additional revenue opportunities through collaborative projects. Furthermore, Razor Labs may capitalize on licensing its technology to other businesses, creating a steady stream of income from intellectual property. The combination of these revenue streams, along with a focus on expanding its client base and enhancing service offerings, contributes significantly to its earnings.
Razor Labs Financial Statement Overview
Summary
Strong TTM revenue growth (23.62%) and sharply improved free cash flow growth (84.50%), but overall fundamentals are pressured by persistent negative profitability (net profit/EBIT/EBITDA margins), negative operating cash flow, and elevated leverage (debt-to-equity 1.56) with negative ROE.
Income Statement
30
Negative
Razor Labs shows a strong revenue growth rate of 23.62% in the TTM, indicating potential for future expansion. However, the company struggles with profitability, as evidenced by negative net profit, EBIT, and EBITDA margins. The gross profit margin has improved slightly over time, but the persistent losses highlight significant operational challenges.
Balance Sheet
40
Negative
The company's debt-to-equity ratio has improved from previous years but remains relatively high at 1.56 in the TTM, indicating a leveraged position. Return on equity is negative, reflecting ongoing losses. The equity ratio is not explicitly provided, but the high leverage suggests a need for careful financial management to avoid solvency risks.
Cash Flow
35
Negative
Razor Labs has shown a significant improvement in free cash flow growth, with an 84.50% increase in the TTM. However, operating cash flow remains negative, and the operating cash flow to net income ratio is unfavorable. The free cash flow to net income ratio is positive, indicating some ability to generate cash relative to net losses.
Breakdown
TTM
Dec 2024
Dec 2023
Dec 2022
Dec 2021
Dec 2020
Income Statement
Total Revenue
27.87M
17.22M
5.29M
5.14M
14.20M
22.30M
Gross Profit
12.17M
7.14M
648.00K
1.60M
1.91M
11.23M
EBITDA
-13.84M
-10.81M
-13.70M
-23.32M
-36.45M
1.50M
Net Income
-16.60M
-15.48M
-18.33M
-27.56M
-41.57M
-7.00K
Balance Sheet
Total Assets
55.60M
79.93M
82.82M
71.30M
101.22M
23.48M
Cash, Cash Equivalents and Short-Term Investments
38.22M
55.29M
58.63M
44.52M
71.12M
2.04M
Total Debt
4.89M
18.28M
20.68M
23.23M
22.71M
11.90M
Total Liabilities
52.44M
68.77M
57.23M
28.49M
31.34M
18.86M
Stockholders Equity
3.14M
11.14M
25.57M
42.80M
69.88M
4.61M
Cash Flow
Free Cash Flow
-6.75M
-567.00K
17.11M
-23.98M
-36.43M
1.27M
Operating Cash Flow
-6.51M
-308.00K
17.25M
-23.84M
-32.78M
1.53M
Investing Cash Flow
-15.02M
6.96M
-7.47M
42.34M
-45.22M
812.00K
Financing Cash Flow
-2.83M
-2.83M
-2.38M
-3.17M
105.08M
-1.19M
Razor Labs Technical Analysis
Technical Analysis Sentiment
Positive
Last Price581.10
Price Trends
50DMA
380.13
Positive
100DMA
200DMA
Market Momentum
MACD
4.61
Positive
RSI
55.12
Neutral
STOCH
40.23
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IL:RZR, the sentiment is Positive. The current price of 581.1 is above the 20-day moving average (MA) of 399.56, above the 50-day MA of 380.13, and equal to the 200-day MA of ―, indicating a neutral trend. The MACD of 4.61 indicates Positive momentum. The RSI at 55.12 is Neutral, neither overbought nor oversold. The STOCH value of 40.23 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IL:RZR.
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jan 04, 2026